Novo Nordisk (spons. ADRs) Aktie
65,40
EUR
-1,20
EUR
-1,80
%
71,71
USD
-1,86
USD
-2,53
%
Werbung
Novo Nordisk (spons. ADRs) Aktie Analyse
15.10.12 | Novo Nordisk (spons. ADRs) kaufen | Euro am Sonntag | |
30.04.12 | Novo Nordisk (spons. ADRs) buy | Citigroup Corp. | |
09.07.07 | Novo Nordisk (spons. ADRs) | Global Biotech Investing | |
14.12.06 | Novo Nordisk (spons. ADRs) Buy | Citigroup | |
08.12.05 | Novo Nordisk (spons. ADRs) Outperform | Bear Stearns |
Werbung
Werbung